REPRISE II EXTENSION

A prospective, single-arm, multi-centre study designed to evaluate the safety & performance of the Lotus Valve System for TAVI in symptomatic patients with severe calcific aortic stenosis considered high risk for surgical valve replacement.

  • 16 sites
  •  Available valve sizes: 23mm & 27mm
  • Follow-up at 7 days/discharge, 30 days, 3 & 6 months, annually 1-5 years